Anthropic CEO predicts AI could end cancer in a decade, drugmakers disagree

Dario Amodei, CEO of Anthropic, the company behind Claude AI, recently predicted that cancer, Alzheimer's, heart disease, and mental illness could become history in less than ten years. He believes AI can greatly speed up biology research and drug development.

Elon Musk and Google AI chief Demis Hassabis agree. Hassabis said AI could shrink ten years of drug development into weeks. His AlphaFold project has already predicted over 200 million protein structures.

The drug industry isn't convinced. Vertex Pharmaceuticals tested about 50 AI companies, and none could independently develop a usable drug. A full drug usually takes 10 to 12 years, and clinical trials and approvals can't be skipped. As of 2026, no AI-designed drug has reached full clinical use.

Medical experts warn such bold predictions may raise public hopes beyond what's possible today. There's still a long road from speeding up research to curing complex diseases.